Arthur Tzianabos's Net Worth
Arthur Tzianabos's net worth is estimated to be at least $3,376,669.36 as of 12/23/2024. CoreStreet's estimation of Arthur Tzianabos's net worth is based on their sale of stock and current holding of stock.
Arthur Tzianabos is Director at Homology Medicines Inc. They have executed at least 12 trades of stock as per SEC Form 4 filings. Their most recent trade was for 10,616 units of FIXX stock on 01/09/2023. Their biggest sale was on 11/23/2020 when they sold 20,000 units of Stoke Therapeutics Inc stock for $920,600.00. They typically trade 2 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $3,376,669.36
Most recent insider trade:
- Jan. 9, 2023
Arthur Tzianabos's Insider Trading History
| Homology Medicines Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 9, 2023 | Director | 10,616 | $1.39 | Sell | $14,756.24 |
Jan. 5, 2022 | CEO | 5,354 | $3.78 | Sell | $20,238.12 |
Jan. 2, 2020 | CEO | 12,500 | $20.50 | Sell | $256,250.00 |
Dec. 2, 2019 | CEO | 12,500 | $16.25 | Sell | $203,125.00 |
Nov. 29, 2019 | CEO | 12,500 | $16.04 | Sell | $200,500.00 |
Oct. 1, 2019 | CEO | 12,500 | $17.40 | Sell | $217,500.00 |
Sept. 3, 2019 | CEO | 12,500 | $18.75 | Sell | $234,375.00 |
Aug. 1, 2019 | CEO | 12,500 | $17.37 | Sell | $217,125.00 |
July 1, 2019 | CEO | 12,500 | $18.98 | Sell | $237,250.00 |
June 3, 2019 | CEO | 12,500 | $19.86 | Sell | $248,250.00 |
| Stoke Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 19, 2021 | Director | 10,000 | $60.67 | Sell | $606,700.00 |
Nov. 23, 2020 | Director | 20,000 | $46.03 | Sell | $920,600.00 |